Additional file 1: Table S1. of Quality assurance of human papillomavirus (HPV) testing in the implementation of HPV primary screening in Norway: an inter-laboratory reproducibility study

EngesĂŚter, Birgit; van Diermen Hidle, Bianca; Hansen, Mona; Moltu, Pia; Staby, Kjersti; Borchgrevink-Persen, Siri; Vintermyr, Olav; LĂśnnberg, Stefan; NygĂĽrd, Mari; Janssen, Emiel; Castle, Philip; Christiansen, Irene

doi:10.6084/m9.figshare.c.3617414_D1.v1

12879_2016_2028_MOESM1_ESM.docx (18.6 kB)

Additional file 1: Table S1. of Quality assurance of human papillomavirus (HPV) testing in the implementation of HPV primary screening in Norway: an inter-laboratory reproducibility study

journal contribution

posted on 2016-11-24, 05:00 authored by Birgit EngesĂŚter, Bianca van Diermen Hidle, Mona Hansen, Pia Moltu, Kjersti Staby, Siri Borchgrevink-Persen, Olav Vintermyr, Stefan LĂśnnberg, Mari NygĂĽrd, Emiel Janssen, Philip Castle, Irene Christiansen

Ct-values for HPV and beta-globin detection in samples with discordant results. The Ct-values of the discordant samples were generally above 38.4 (with two exceptions), and hence close to the clinical Ct cut-off values. The Ct-values of beta-globin were for all samples between 25.5 and 28, indicating sufficient quality of the input DNA. (DOCX 18 kb)